This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Cedarburg Pharmaceuticals, Inc., Inspyr Therapeutics, Inc., Genspera, Inc.. Active years: 2012-2017.
Location History:
- Plymouth, IN (US) (2012 - 2017)
- Plymouth, IN (2017)
Company Filing History:
2 out of 3 
2 out of 2 
1 out of 8 
Years Active: 2012-2017
Title: Kevin Kunnen: Innovator in Cancer Treatment
Introduction
Kevin Kunnen is a notable inventor based in Plymouth, Indiana, who has made significant contributions to the field of cancer treatment. With a total of five patents to his name, he has focused on developing methods that target cancer effectively.
Latest Patents
Among his latest patents are innovative methods for producing cancer-targeting compounds. These patents detail the processes involved in creating specific compounds and the intermediates necessary for their production. Additionally, he has developed methods for producing cancer-treating compounds, further showcasing his commitment to advancing cancer therapies.
Career Highlights
Throughout his career, Kevin has worked with reputable companies such as Inspyr Therapeutics, Inc. and Cedarburg Pharmaceuticals, Inc. His work in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to the development of new cancer treatments.
Collaborations
Kevin has collaborated with several professionals in his field, including John K. Lynch and Jeff Hutchison. These partnerships have enabled him to enhance his research and expand the impact of his inventions.
Conclusion
Kevin Kunnen's work in cancer treatment exemplifies the importance of innovation in medicine. His patents and collaborations reflect a dedication to improving patient outcomes through targeted therapies.